Literature DB >> 25150094

Regadenoson-induced bradycardia and hypotension: possible mechanism and antidote.

S R Underwood1, K A Latus, E Reyes, K Standbridge, S Walker, K Wechalekar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25150094     DOI： 10.1007/s12350-014-9968-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  2 in total

1.  Asystole following regadenoson infusion in stable outpatients.

Authors:  Jeffrey Rosenblatt; Deirdre Mooney; Timothy Dunn; Mylan Cohen
Journal:  J Nucl Cardiol       Date:  2014-05-31       Impact factor: 5.952

2.  Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy.

Authors:  M Brinkert; E Reyes; S Walker; K Latus; A Maenhout; R Mizumoto; C Nkomo; K Standbridge; K Wechalekar; S R Underwood
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-22       Impact factor: 9.236
  2 in total
  5 in total

Review 1.  Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies.

Authors:  Vasken Dilsizian; Henry Gewirtz; Nicholas Paivanas; Anastasia N Kitsiou; Fadi G Hage; Nathan E Crone; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2015-05-15       Impact factor: 5.952

2.  Serious complications associated with regadenoson administration for myocardial perfusion imaging: a commentary.

Authors:  Fadi G Hage; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2014-10       Impact factor: 5.952

3.  Adverse effects associated with regadenoson myocardial perfusion imaging.

Authors:  Efstathia Andrikopoulou; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2018-02-21       Impact factor: 5.952

4.  Incidence of atrioventricular block with vasodilator stress SPECT: A meta-analysis.

Authors:  Efstathia Andrikopoulou; Charity J Morgan; Lizbeth Brice; Navkaranbir S Bajaj; Harish Doppalapudi; Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-10-17       Impact factor: 5.952

5.  Regadenoson in Myocardial Perfusion Study - First Institutional Experiences in Bosnia and Herzegovina.

Authors:  Nermina Beslic; Renata Milardovic; Amera Sadija; Sejla Ceric; Zeljka Raic
Journal:  Acta Inform Med       Date:  2016-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.